Page 1512 - Williams Hematology ( PDFDrive )

1486 Part X: Malignant Myeloid Diseases Chapter 89: Chronic Myelogenous Leukemia and Related Disorders 1487

820. Matsuo T, Tomonaga M, Kuriyama K, et al: Prognostic significance of the morpholog- 856. Greaves MF, Verbi W, Reeves BR, et al: “Pre-B” phenotypes in blast crisis of Ph1 posi-
ical dysplastic changes in chronic myelogenous leukemia. Leuk Res 10:331, 1986. tive CML: Evidence for a pluripotential stem cell “target.” Leuk Res 3:181, 1979.
821. Specchia G, Palumbo G, Pastore D, et al: Extramedullary blast crisis in chronic mye- 857. Bakhshi A, Minowada J, Arnold A, et al: Lymphoid blast crisis of chronic myeloge-
loid leukemia. Leuk Res 20:905, 1996. nous leukemia represents stages in the development of B-cell precursors. N Engl J Med
822. Inveradi D, Lazzarino M, Morra E, et al: Extramedullary disease in Ph-positive 309:826, 1983.
chronic myelogenous leukemia: Frequency, clinical features, prognostic significance. 858. Griffin JD, Todd RF, Ritz J, et al: Differentiation patterns in the blastic phase of chronic
Haematologica 75:146, 1990. myeloid leukemia. Blood 61:85, 1983.
823. Jacknow J, Fizzera G, Gajl-Peczalska K, et al: Extramedullary presentation of the blast 859. Bollum FJ: Terminal deoxynucleotidyl transferase, in The Enzymes, edited by Boyer
crisis of chronic myelogenous leukemia. Br J Haematol 61:225, 1985. RD, p 145. Academic, New York, 1974.
824. Terjanian T, Kantarjian H, Keating M, et al: Clinical and prognostic features of 860. Dorfman DM, Longtine JA, Fox EA, et al: T-cell blast crisis in chronic myelogenous
patients with Philadelphia chromosome-positive chronic myelogenous leukemia and leukemia. Am J Clin Pathol 107:168, 1997.
extramedullary disease. Cancer 59:297, 1987. 861. Allouche M, Bourinbaiar A, Georgoulias V, et al: T-cell lineage involvement in lym-
825. Miksanek T, Reyes CV, Semkuo Z, Molnar ZJ: Granulocytic sarcoma of the perito- phoid blast crisis of chronic myeloid leukemia. Blood 66:1155, 1985.
neum. CA Cancer J Clin 33:40, 1983. 862. Gramatzki M, Bartram CR, Muller D, et al: Early T-cell differentiated chronic myeloid
826. Jones TI: Pleural blast crisis in chronic myelogenous leukemia. Am J Hematol 44:75, leukemia blast crisis with rearrangement of the breakpoint cluster region but not of
1993. the T-cell receptor beta chain genes. Blood 69:1082, 1987.
827. Pascoe HR: Tumors composed of immature granulocytes occurring in the breast in 863. Dastugue N, Kuhlein E, Duchayne E, et al: T(14:14)(q11;q32) in biphenotypic blastic
chronic granulocytic leukemia. Cancer 25:697, 1970. phase of chronic myeloid leukemia. Blood 68:949, 1986.
828. Chabner BA, Haskell CM, Canellos GP: Destructive bone lesions in chronic granulo- 864. Kuriyama K, Tomonaga M, Yao E, et al: Dual expression of lymphoid/basophil mark-
cytic leukemia. Medicine (Baltimore) 48:401, 1969. ers on single blast cells transformed from chronic myeloid leukemia. Leuk Res 10:1015,
829. Licht A, Many N, Rachmilewitz EA: Myelofibrosis, osteolytic bone lesions and hyper- 1986.
calcemia in chronic myeloid leukemia. Acta Haematol 49:182, 1973. 865. Yasukawa M, Iwamasa K, Kawamura S, et al: Phenotypic and genotypic analysis of
830. Lee CH, Morris TCM: Bone marrow necrosis and extramedullary myeloid tumor chronic myelogenous leukaemia with T lymphoblastic and megakaryoblastic mixed
necrosis in aggressive chronic myeloid leukemia. Pathology 11:551, 1979. crisis. Br J Haematol 66:331, 1987.
831. Asarro S, Sato N, Ueshima Y, et al: Localized blastoma preceding blastic transforma- 866. Spencer A, Vulliamy T, Chase A, et al: Myeloid to lymphoid clonal suppression follow-
tion in Ph1-positive chronic myelogenous leukemia. Scand J Haematol 25:251, 1980. ing autologous transplantation in second chronic phase of chronic myeloid leukemia.
832. Ohyashiki K, Ito H: Characterization of extramedullary tumors in a case of Ph- Leukemia 9:2138, 1995.
positive chronic myelogenous leukemia. Cancer Genet Cytogenet 15:119, 1985. 867. Cervantes F, Villamor N, Esteve J, et al: “Lymphoid” blast crisis of chronic myeloid
833. Sun T, Susin M, Koduru P, et al: Extramedullary blast crisis in chronic myelogenous leukaemia is associated with distinct clinicohaematological features. Br J Haematol
leukemia. Cancer 68:605, 1991. 100:123, 1998.
834. Saikia TK, Dhabhar B, Iyer RS, et al: High incidence of meningeal leukemia in lym- 868. Stoll C, Oberline F: Non-random clonal evolution in 45 cases of chronic myeloid
phoid blast crisis of chronic myelogenous leukemia. Am J Hematol 43:10, 1993. leukemia. Leuk Res 46:61, 1980.
835. Falini B, Tabilio A, Pelicci PG, et al: T-cell receptor B-chain gene rearrangement in a 869. Sandberg AA: The cytogenetics of chronic myelocytic leukemia (CML): Chronic
case of Ph1-positive chronic myeloid leukaemia blast crisis. Br J Haematol 62:776, 1986. phase and blastic crisis. Cancer Genet Cytogenet 1:217, 1980.
836. Giannone L, Whitlock JA, Kinney MC, et al: Use of the BCR probe to demonstrate 870. Myint H, Ross FM, Hall JL, et al: Early transformation to acute myeloblastic leu-
extramedullary recurrence of CML with a T cell lymphoid phenotype following bone kaemia with the acquisition of inv(16) in Ph positive chronic granulocytic leukaemia.
marrow transplantation. Bone Marrow Transplant 3:631, 1988. Leuk Res 21:473, 1997.
837. Ohyashiki J, Ohyashiki K, Shimizu H, et al: Testicular tumor as the first manifestation 871. Johansson B, Fioretos T, Mitelman F: Cytogenetic and molecular genetic evolution of
of B-lymphoid blastic crisis in a case of Ph-positive chronic myelogenous leukemia. chronic myeloid leukemia. Acta Haematol 107:76, 2002.
Am J Hematol 29:164, 1988. 872. Sandberg AA: Chronic myelocytic leukemia, in The Chromosomes in Human Cancer
838. Rosenthal S, Canellos GP, DeVita VT Jr, Gralnick HR: Characteristics of blast crisis in and Leukemia, 2nd ed, p 465. Elsevier North Holland, New York, 1990.
chronic granulocytic leukemia. Blood 49:705, 1977. 873. Mitani K, Miyazono K, Urabe A, Takaku F: Karyotypic changes during the course of
839. Barton JC, Conrad ME: Current status of blastic transformation in chronic myeloge- blastic crisis of chronic myelogenous leukemia. Cancer Genet Cytogenet 39:299, 1989.
nous leukemia. Am J Hematol 4:281, 1978. 874. Diez-Martin JL, DeWald GW, Pierre RV, et al: Possible cytogenetic distinction
840. Peterson LC, Bloomfield CD, Brunning RD: Blast crisis as an initial or terminal man- between lymphoid and myeloid blast crisis in chronic granulocytic leukemia. Am J
ifestation of chronic myeloid leukemia. Am J Med 60:209, 1976. Hematol 27:194, 1988.
841. Bettelheim P, Lutz D, Majdic O, et al: Cell lineage heterogeneity in blast crisis of 875. Feinstein E, Cimino G, Gale RP, Canaani E: Initiation and progression of chronic mye-
chronic myeloid leukaemia. Br J Haematol 59:395, 1985. logenous leukemia. Leukemia 6(Suppl 1):37, 1992.
842. Nair C, Chopra M, Shinde S, et al: Immunophenotype and ultrastructural studies in 876. Brizard F, Cividin M, Villalva C, et al: Comparison of M-FISH and conventional cyto-
blast crisis of chronic myeloid leukemia. Leuk Lymphoma 19:309, 1995. genetic analysis in accelerated and acute phases of CML. Leuk Res 28:345, 2004.
843. Rosenthal S, Canellos GP, Gralnick HR: Erythroblastic transformation of chronic 877. Heim S, Christensen EB, Fioretos T, et al: Acute myelomonocytic leukemia with
granulocytic leukemia. Am J Med 63:116, 1977. inv(16) (p13q22) complicating Philadelphia chromosome positive chronic myeloid
844. Ekblom M, Borgstrom G, von Willebrand E, et al: Erythroid blast crisis in chronic leukemia. Cancer Genet Cytogenet 59:35, 1992.
myelogenous leukemia. Blood 62:591, 1983. 878. Hogge DE, Misawa S, Testa JR, et al: Unusual karyotypic changes and B-cell involve-
845. Lingg G, Schmalzl F, Breton-Gorius J, et al: Megakaryoblastic micro-megakaryocytic ment in a case of lymph node blast crisis of chronic myelogenous leukemia. Blood
crisis in chronic myeloid leukemia. Blut 51:275, 1985. 64:123, 1984.
846. Castaigne S, Berger R, Jolly V, et al: Promyelocytic blast crisis of chronic myelocytic 879. Kantarjian H, Talpaz M, O’Brien S, et al: Survival benefit with imatinib mesylate ther-
leukemia with both t(9;22) and t(15;17) in M3 cells. Cancer 54:2409, 1984. apy in patients with accelerated-phase chronic myelogenous leukemia—Comparison
847. Berger R, Bernheim A, Daniel MT, Flandrin G: T(15;17) in a promyelocytic form of with historic experience. Cancer 103:2099, 2005.
chronic myeloid leukemia blastic crisis. Cancer Genet Cytogenet 8:149, 1983. 880. Shah NP: Advanced CML: Therapeutic options for patients in accelerated and blast
848. Misawa S, Lee E, Schiffer CA, et al: Association of translocation (15;17) with malig- phases. J Natl Compr Canc Netw 6 Suppl 2:S31, 2008.
nant proliferation of promyelocytes in acute leukemia and chronic myelogenous leu- 881. Fruehauf S, Topaly J, Buss EC, et al: Imatinib combined with mitoxantrone/etoposide
kemia in blast crisis. Blood 67:270, 1986. and cytarabine is an effective induction therapy for patients with chronic myeloid
849. Marinone G, Rossi G, Verzura P: Eosinophilic blast crisis in a case of chronic myeloid leukemia in myeloid blast crisis. Cancer 109:1543, 2007.
leukaemia. Br J Haematol 55:251, 1983. 882. Cortes J, Kantarjian H: Advanced-phase chronic myeloid leukemia. Semin Hematol
850. Goh KO, Anderson FW: Cytogenetic studies in basophilic chronic myelocytic leuke- 40:79, 2003.
mia. Arch Pathol Lab Med 103:288, 1979. 883. Druker BJ, Sawyers CL, Kantarjian H, et al: Activity of a specific inhibitor of the
851. Rosenthal NS, Knapp D, Farhi DC: Promyelocytic blast crisis of chronic myelogenous BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute
leukemia. A rare subtype associated with disseminated intravascular coagulation. Am lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344:1038,
J Clin Pathol 103:185, 1995. 2001.
852. Lemes A, Gomez Casares MT, de la Iglesia S, et al: P190 BCR-ABL rearrangement in 884. Altintas A, Cil T, Kilinc I, et al: Central nervous system blastic crisis in chronic mye-
chronic myeloid leukemia and acute lymphoblastic leukemia. Cancer Genet Cytogenet loid leukemia on imatinib mesylate therapy: A case report. J Neurooncol 84:103, 2007.
113:100, 1999. 885. Simpson E, O’Brien SG, Reilly JT: Extramedullary blast crises in CML patients in
853. Bertazzoni U, Brusamolino E, Isernia P, et al: Diagnostic significance of terminal complete hematological remission treated with imatinib mesylate. Clin Lab Haematol
transferase and adenosine deaminase in acute and chronic myeloid leukemia. Blood 28:215, 2006.
60:685, 1982. 886. Gozzetti A, Bocchia M, Calabrese S, et al: Promyelocytic blast crisis of chronic myel-
854. Schuh AC, Sutherland DR, Horsfall W, et al: Chronic myeloid leukemia arising in a ogenous leukemia during imatinib treatment. Acta Haematol 117:236, 2007.
progenitor common to T cells and myeloid cells. Leukemia 4:631, 1990. 887. Kantarjian HM, Cortes J, O’Brien S, et al: Imatinib mesylate (STI571) therapy for
855. Uike N, Takeichi N, Kimura N, et al: Dual arrangement of immunoglobulin and T-cell Philadelphia chromosome–positive chronic myelogenous leukemia in blast phase.
receptor genes in blast crisis of CML. Eur J Haematol 42:460, 1989. Blood 99:3547, 2002.

Kaushansky_chapter 89_p1437-1490.indd 1487 9/18/15 3:42 PM